Federal award
REJUVENATE BIO INC.
H9240521C0015
ContractSBIR/STTR ST2
Obligated and Ceiling
- Obligated (net)
- $2,146,157.51
- Ceiling (potential value, not spending)
- $2,146,157.51
- Current value
- $2,146,157.51
- Gross positive obligations
- $2,247,757.54
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- REJUVENATE BIO INC. · GEKFSVSTKK55
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- REJUVENATE BIO INC. · GEKFSVSTKK55
- Awarding agency
- Department of War · sub-agency 97ZS · office H92405
- Funding agency
- Department of War · sub-agency 97ZS
- Product or service (PSC)
- AC13 · NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; EXPERIMENTAL DEVELOPMENT
- Industry (NAICS)
- 541714 · RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
- PIID
- H9240521C0015
- Award type code
- D
- Actions
- 10 · Sep 8, 2021 to May 17, 2024
- Why it is listed
- gross positive obligations of $100k or more (contracts); SBIR/STTR award
Action History10
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| May 17, 2024 | FY2024 | P00008 | M | $0.00 | — |
| Mar 12, 2024 | FY2024 | P00007 | B | $0.00 | — |
| Aug 15, 2023 | FY2023 | P00006 | B | $0.00 | — |
| Mar 8, 2023 | FY2023 | ARZ999 | W | $0.00 | — |
| Feb 1, 2023 | FY2023 | P00005 | B | $646,576.51 | — |
| Aug 25, 2022 | FY2022 | P00004 | M | $0.00 | — |
| Sep 29, 2021 | FY2021 | P00003 | C | $629,581.00 | — |
| Sep 15, 2021 | FY2021 | P00002 | C | $101,600.03 | — |
| Sep 13, 2021 | FY2021 | P00001 | C | −$101,600.03 | — |
| Sep 8, 2021 | FY2021 | 0 | — | $870,000.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.